Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Eli Lilly’s Tabalumab Fails over Efficacy in Phase 3 Trial

Though, tabalumab's Phase II clinical studies showed success and proved effective, a recent report has revealed that Eli Lilly and Company's human monoclonal antibody failed in terms of meeting efficacy objectives in a next-stage trial.

Of total three Phase 3 rheumatoid arthritis registration studies, one study of the anti-BAFF monoclonal antibody failed, which the researchers say, was totally unexpected. However, the failure is in no way related to safety concerns.

Therefore, as per the findings, patients currently involved in other studies of tabalumab RA would continue the treatment. Lilly would also be working towards the development of additional treatment options so that patients with autoimmune diseases could have an option.

It has been told that the company would evaluate the candidate in two other studies related to Phase 3 RA registration following the open-label extension study as well as other smaller studies. Since, the company is of the belief that it does not have sufficient data to gain U. S. marketing clearance.

"We remain committed to patients with rheumatoid arthritis and lupus and will move rapidly to evaluate the impact of these data on the overall tabalumab clinical development programme", sources quoted vice president for Lilly autoimmune product development Eiry Roberts as saying.


FrenchTribune Specials

Sun Halos in Florida Sky

If you noticed, sky today showed a new scene and i.e. a colorful circle formation around the sun. Yes, according to the reports coming from the experts and also, the statements of a few gazers, shortly after noon today, 'Sun Halo' was spotted.

Explaining to the viewers what exactly happened to the sun at that time, the experts from the...

Most Popular

Chimps Give Same Care and Attention to Beds as Humans

Well, you must not underestimate chimps when it comes to...

CDC Reports Decline in Health Complications due to Diabetes in United States

Researchers from the Centers for Disease Control and...

Bill Nye Underestimated Impact of Debate with Creationist Ken Ham

TV's Science Guy, Bill Nye, entered into a debate with...

Ensuring Food Security during Climate Change Requires Farmers to Adapt

It is just the fourth month of the year and already...

Poll

Can Greece Come out of Economic Problems: